WebApr 15, 2024 · The injectable glucagon-like peptide-1 (GLP-1) receptor agonist semaglutide (Wegovy) has been approved by the FDA to reduce the risk of major adverse cardiovascular events (MACE) in adults with established cardiovascular disease (CVD) and either obesity or overweight.1,2 Semaglutide is the first drug to be approved for cardiovascular risk …
DA:83PA:41MOZ Rank:36
Continuing Medical Education Exam Status | The Medical Letter, …
WebContinuing Medical Education Exam Status. You must be logged in to access CME exams. Login now. The Medical Letter has provided trusted prescription drug information and drug facts since 1959.
DA:42PA:12MOZ Rank:62
Continuing Medical Education | The Medical Letter, Inc.
WebContinuing Medical Education. The Medical Letter’s self-study CME program, which is based on content of our newsletter, The Medical Letter On Drugs and Therapeutics, is designed for healthcare professionals including physicians, nurse practitioners, physician assistants, and pharmacists. Earn up to 52 credits per year.
DA:97PA:42MOZ Rank:29
Subscription to The Medical Letter | The Medical Letter, Inc.
WebThe Medical Letter On Drugs and Therapeutics is a biweekly publication that provides: Evidence-based, peer-reviewed evaluations of new FDA-approved drugs with conclusions reached by a consensus of experts. New information on previously approved drugs including pivotal clinical trials, new indications, and safety warnings.
DA:7PA:71MOZ Rank:63
The Medical Letter, Inc. | The Medical Letter, Inc.
WebThe Medical Letter, Inc. was founded in 1958 by Arthur Kallet, the co-founder of Consumers Union, and Dr. Harold Aaron. Arthur Kallet. Kallet was an engineer who co-wrote the book 100,000,000 Guinea Pigs, a best-seller in the 1920s. Some say it played an important part in the Food and Drug Act of 1938, which required for the first time that ...
DA:57PA:100MOZ Rank:61
The Medical Letter - 2023 | The Medical Letter Inc.
WebMarch 6, 2023 (Issue 1671) Antiviral Drugs for COVID-19 in Vaccinated Outpatients. Free. Three products are currently available in the US for treatment of high-risk,1 nonhospitalized adults with mild to moderate COVID-19: oral ritonavir-boosted nirmatrelvir (Paxlovid), IV remdesivir (Veklury),...
WebEmergency Use Authorization (EUA) of the Pfizer-BioNTech COVID-19 vaccine to prevent coronavirus disease 2019 (COVID-19). For 12 years of age and older. March 29, 2022. Available at: https://bit.ly/3bBH5GV. Accessed March 31, 2022. FDA. Fact sheet for healthcare providers administering vaccine (vaccination providers).
DA:86PA:66MOZ Rank:73
The Medical Letter Mobile Collection | The Medical Letter, Inc.
WebMar 30, 2024 · Download The Medical Letter’s FREE app for iOS, Android, and Kindle Fire. The Medical Letter Mobile Collection enables you to get the latest issue of The Medical Letter On Drugs and Therapeutics when and where you need it on your mobile device. Browse past issues, earn CME/CE credits on the go, or find information quickly by using …
WebApr 17, 2024 · Contact Us. The Medical Letter, Inc. 145 Huguenot St., Suite 312. New Rochelle, NY 10801-7537. Phone: (800) 211-2769. (914) 235-0500. Fax: (914) 632-1733.
DA:90PA:77MOZ Rank:60
The Medical Letter - Issue 1639 | The Medical Letter Inc.
WebTitle: Issue 1639. Downloadable, electronic issue - $45. Add to cart. Gain access through your organization. Ask your librarian to consider an Institutional Subscription to The Medical Letter. Recommend to your librarian. The Medical Letter has provided trusted prescription drug information and drug facts since 1959.
DA:59PA:90MOZ Rank:21
Fillable Online medicalletter.orgThe Medical Letter